The Hepatitis Testing Market research report classifies the market trends relevant to the supply, requirement, and arrangement, at any rate, the new events. The report highlights huge drivers, restrictions, and positive chances to give a definite image of the market. The Hepatitis Testing Market research report gives complete details about the profitable emerging markets and examines insights into the markets' developing section. Furthermore, the Hepatitis Testing Market research report gives a complete evaluation of market shares, approaches, products, verification, regulatory approvals, copyright aspect, and manufacturing proficiency of the leading players.

Hepatitis Testing/Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Market Overview

The global hepatitis testing market is projected to reach USD 2.8 billion in 2021, at a CAGR of 6.7% during the forecast period.

Get a Sample Copy of the Report: https://www.delvens.com/get-free-sample/hepatitis-testing-market-trends-forecast-till-2028

The term Hepatitis broadly means inflammation of the liver. Heavy alcohol use, some medications, toxins, and certain medical conditions can cause hepatitis. However, hepatitis is often caused due to viral infection. The most common types of viral hepatitis are hepatitis A, hepatitis B, and hepatitis C.

The high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on hepatitis are some of the factors that have supported the long-term expansion for the Hepatitis Testing/Diagnosis Market.

The COVID-19 outbreak had a negative impact on the hepatitis testing market due to decreasing patient visits to hospitals. The pandemic has put a significant strain on healthcare systems. Healthcare institutes and providers were instructed to stop performing elective surgical procedures and medical examinations to slow the spread of the disease and conserve healthcare resources for COVID-19 patients.

Regional Analysis

In 2020, North America dominates the global market, and this trend is expected to continue during the forecast period. The large share and high growth of this region can be attributed to the rising prevalence of hepatitis and increased research and clinical trials for hepatitis testing in the US.

Key Players

·         Abbott Laboratories

·         Danaher Corporation

·         BioMerieux SA

·         Bio-Rad Laboratories Inc

·         Diasorin S.p.A

·         F. Hoffmann-La Roche AG

·         Hologic Inc

·         MedMira Inc

·         Qaigen Inc

·         Siemens Healthineers

To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/hepatitis-testing-market-trends-forecast-till-2028

Recent Developments

·         In 2021, Abbott received FDA Emergency Use Authorization (EUA) for the Alinity m Resp-4-Plex assay.

·         In 2021, F.Hoffmann-La Roche Ltd. acquired GenMark Diagnostics (US) which aimed at adding more products to Roche’s molecular diagnostics portfolio and the global distribution of products offered by GenMark Diagnostics.

Reasons to Acquire

·         Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors

·         Gain authentic and granular data access for Hepatitis Testing/Diagnosis Market so as to understand the trends and the factors involved behind changing market situations

·         Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

·         In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Table of Contents

Hepatitis Testing/Diagnosis Market is segmented into disease type, technology, end user and region.

 

On the basis of Disease Type

·         Hepatitis B (HBV)

·         Hepatitis C (HCV)

On the basis of Technology 

·         Enzyme-linked Immunosorbent Assay (ELISA)

·         Rapid Diagnostic Tests (RDT)

·         Polymerase Chain Reaction (PCR)

·         Isothermal Nucleic Acid Amplification Technology (INAAT)

On the basis of End-User 

·         Hospital & Diagnostic Laboratories

·         Blood Banks

On the basis of Region

·         Asia Pacific

·         North America

·         Europe

·         South America

·         Middle East & Africa

Get Direct Order of this Report: https://www.delvens.com/checkout/hepatitis-testing-market-trends-forecast-till-2028

 

Browse Related Reports:

Digital Therapeutics (DTx) Market – Trends Forecast Till 2030

Mapping Catheters Market – Trends Forecast Till 2030

Occupational Therapy Software Market – Trends Forecast Till 2030

FAQs?

What is the market report for hepatitis B?

Which companies dominate the Hepatitis Testing Market?

What predictions for the future can help with strategic decision-making?

What advantages does Hepatitis Testing Market offer businesses?

 

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports, and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to significant markets, serving more than 1K prominent companies by assuring to provide information on the country, regional, and global business environment. We have a database for more than 45 industries globally in more than 115+ significant countries.

Delvens database assists clients by providing in-depth information on crucial business decisions. Delvens offers significant facts and figures across various industries: Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, and Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM